---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-097591"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:28:45.889677+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Humacyte prices $60M registered direct offering of common stock and warrants

## Summary
- Raised $60.0M via sale of 28.4M shares and warrants to purchase 28.4M shares at $2.11 per unit.
- Warrants exercisable at $2.11, become exercisable 180 days after issuance, expire April 7, 2031.
- Offering oversubscribed with institutional investors; expected to close October 8, 2025.
- D. Boral Capital acting as exclusive placement agent; fee equal to 5.75% of gross proceeds.
- Offered under effective shelf registration statement (File No. 333-290231) declared effective Sept 22, 2025.

## SEC filing metadata
- accession: 0001104659-25-097591
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/0001104659-25-097591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/tm2528189d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-097591
- JSON: https://secwatch.observer/filing/0001104659-25-097591.json
- Plain text: https://secwatch.observer/filing/0001104659-25-097591.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.